Irving and Brooklyn go to Doncic and the Mavericks | Sports activities

Brooklyn Nets (43-23, second in Eastern Conference) v Dallas Mavericks (37-28, fifth in Western Conference)

Dallas; Thursday, 7:30 p.m. EDT

BOTTOM: Luka Doncic and Kyrie Irving meet as Dallas takes on Brooklyn. Doncic is fourth in the NBA with an average of 28.5 points per game and Irving is eighth in the league with an average of 27.0 points per game.

The Mavericks have gone 17-15 in home games. Dallas is sixth in the Western Conference in team defense, allowing only 110 points while opponents shoot 46%.

The nets are 18-15 in street games. Brooklyn ranks ninth in the Eastern Conference with 44.4 rebounds per game, led by James Harden averaging 8.7.

The teams meet for the second time this season. The Mavericks won 115-98 in their last matchup on February 27th. Doncic led Dallas with 27 points and Harden led Brooklyn with 29 points.

TOP PERFORMERS: Doncic leads the Mavericks with 8.9 assists and scores 28.5 points per game. Dorian Finney-Smith shoots 56.0% and averages 12.4 points in the last 10 games for Dallas.

Kevin Durant leads the nets with an average of 28.3 points and collects 6.9 rebounds. Irving averaged 22.4 points and five rebounds in their last 10 games for Brooklyn while shooting 38.0%.

LAST 10 MATCHES: Mavericks: 7-3, averaging 116.2 points, 41.9 rebounds, 22.9 assists, 7.3 steals, and 3.7 blocks per game while 48.5% is shot off the field. Your opponents averaged 111 points at 48.3% shooting.

Nets: 5-5, averaging 116.8 points, 44.8 rebounds, 25.5 assists, 6.7 steals, and 4.6 blocks per game, while 47.3% are shot from the field. Your opponents averaged 116 points at 45.9% shooting.

INJURIES: Outsiders: Tyrell Terry: out (personally), Maxi Kleber: out (Achilles), Kristaps Porzingis: out (knee).

Nets: Spencer Dinwiddie: off for the season (acl), James Harden: off (thigh), Chris Chiozza: off (hand).


The Associated Press created this story using Sportradar technology and data provided by Data Skrive.

© 2021 Data Skrive. All rights reserved.

Comments are closed.